Phonolyser is dedicated to lightening the burden of people dealing with Congenital Heart Disease (CHD). The company provides a smart heart sound analyzer device combining AI, doppler, and sound effects to accurately diagnose CHD. The diagnosis takes only two minutes, saving lives around the world and making an impact on the health of so many.

  • Founding year: 
  • 2017
  • Development phase:
  • Market-ready, with CE mark, estimation Sep 2022
  • Funding stage:
  • Seed, looking for 1,5 to 2 mil Eur
  • Website: 
  • Contact person info:
  • bahmandoaeian(at)gmail.com
  • Team members:
  • 7
  • Article:
  • Read an article about Phonolyser.